Author

Matthew J. O’Shaughnessy

Observed names: M.J. O’Shaughnessy, Matthew J O’Shaughnessy, Matthew J. O'Shaughnessy, Matthew O'Shaughnessy, O'Shaughnessy, M. J.

Observed institutions: University of North Carolina at Chapel Hill, University of Minnesota, Memorial Sloan Kettering Cancer Center, University of Nevada, Reno, Yale University, Stanford Medicine, National Cancer Institute, Weill Cornell Medicine, UNC Lineberger Comprehensive Cancer Center, Masonic Cancer Center, Takeda Oncology (United States), Stanford University

ORCID: 0000-0001-6380-0839

Observed ORCID: 0000-0001-6380-0839

OpenAlex ID: A5022388564

Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib

2004 · Kai Sun, Lisbeth A. Welniak, et al. · Proceedings of the National Academy of Sciences · 244

Hematopoietic reconstitution by multipotent adult progenitor cells: precursors to long-term hematopoietic stem cells

2007 · Marta Serafini, Scott J. Dylla, et al. · The Journal of Experimental Medicine · 114

PDF

Systemic Antitumor Immunity by PD-1/PD-L1 Inhibition Is Potentiated by Vascular-Targeted Photodynamic Therapy of Primary Tumors

2017 · Matthew J. O'Shaughnessy, Katie S. Murray, et al. · Clinical Cancer Research · 99

PDF

Differentiation of Ingested and Endogenous Bifidobacteria by DNA Fingerprinting Demonstrates the Survival of an Unmodified Strain in the Gastrointestinal Tract of Humans , , ,

1997 · Martin J. Kullen, Mary M. Amann, et al. · Journal of Nutrition · 88

PDF

Host factors that impact the biodistribution and persistence of multipotent adult progenitor cells

2006 · Jakub Tolar, Matthew J. O'Shaughnessy, et al. · Blood · 78

PDF

A Pilot Study of a Multimodal Treatment Paradigm to Accelerate Drug Evaluations in Early-stage Metastatic Prostate Cancer

2016 · Matthew J. O'Shaughnessy, Sean M. McBride, et al. · Urology · 70

Multipotent adult progenitor cells can suppress graft-versus-host disease via prostaglandin E2 synthesis and only if localized to sites of allopriming

2009 · Steven L. Highfill, Ryan M. Kelly, et al. · Blood · 59

Late Relapse of Testicular Germ Cell Tumors

2015 · Matthew J. O’Shaughnessy, Darren R. Feldman, et al. · Urologic Clinics of North America · 43

Elevation of Intracellular Cyclic AMP in Alloreactive CD4+ T Cells Induces Alloantigen-Specific Tolerance That Can Prevent GVHD Lethality In Vivo

2007 · Matthew J. O’Shaughnessy, Zong-Ming Chen, et al. · Transplantation and Cellular Therapy · 18

PDF

Ex vivo Inhibition of NF-κB Signaling in Alloreactive T-cells Prevents Graft-Versus-Host Disease

2009 · M.J. O’Shaughnessy, C. Vogtenhuber, et al. · American Journal of Transplantation · 17

Outgrowth of CD4low/negCD25+ T Cells with Suppressor Function in CD4+CD25+ T Cell Cultures upon Polyclonal Stimulation Ex Vivo

2008 · Christine Vogtenhuber, Matthew J O’Shaughnessy, et al. · The Journal of Immunology · 15

PDF

Prostate cancer screening: issues and controversies.

2010 · Matthew O'Shaughnessy, Badrinath Konety, et al. · PubMed · 14

Drug development for noncastrate prostate cancer in a changed therapeutic landscape

2017 · Min Yuen Teo, Matthew J. O'Shaughnessy, et al. · Nature Reviews Clinical Oncology · 10

Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib

2020 · Liu, H., Murphy, W. J., et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill) · 9

Bladder Biopsy of Normal-Appearing Mucosa is Not Helpful in Patients with Unexplained Positive Cytology after Nonmuscle Invasive Bladder Cancer

2014 · John E. Musser, Matthew J. O'Shaughnessy, et al. · The Journal of Urology · 8

Hematopoietic reconstitution by multipotent adult progenitor cells: precursors to long-term hematopoietic stem cells

2007 · Marta Serafini, Scott J. Dylla, et al. · The Journal of Experimental Medicine · 7

PDF

Factors Associated With Reduction in Use of Neoadjuvant Androgen Suppression Therapy Before Radical Prostatectomy

2013 · Matthew J. O'Shaughnessy, Stephanie L. Jarosek, et al. · Urology · 5

Erratum: Drug development for noncastrate prostate cancer in a changed therapeutic landscape

2017 · Min Yuen Teo, Matthew J. O'Shaughnessy, et al. · Nature Reviews Clinical Oncology · 1

PDF

Radical prostatectomy as a component of multimodal therapy for highly selected M1 prostate cancer patients.

2015 · Matthew O'Shaughnessy, James Andrew Eastham, et al. · Journal of Clinical Oncology · 1

Pd27-03 Radical Prostatectomy as a Component of Multimodal Therapy for Highly-selected M1 Prostate Cancer Patients

2014 · Matthew J. O'Shaughnessy, Karim A. Touijer, et al. · The Journal of Urology · 1

Sipuleucel-T immunotherapy in clinical practice: Patient characteristics, tolerability, and survival.

2012 · Matthew O'Shaughnessy, Christopher Warlick, et al. · Journal of Clinical Oncology · 1

Ex vivo Inhibition of NF-κB Signaling in Alloreactive T-cells Prevents Graft-Versus-Host Disease

2020 · Vogtenhuber, C., Baldwin, A. S., et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)

PDF

Pd24-11 Evaluation of a Multimodal Strategy to Accelerate Drug Evaluations in Early Stage Metastatic Prostate Cancer

2017 · Matthew O'Shaughnessy, Sean McBride, et al. · The Journal of Urology

Author Reply

2017 · Matthew J. O'Shaughnessy, Sean M. McBride, et al. · Urology

Evaluation of a multimodal strategy to accelerate drug evaluations in early-stage metastatic prostate cancer.

2017 · Matthew O'Shaughnessy, Sean Matthew McBride, et al. · Journal of Clinical Oncology

Works count: 33

Citation count: 902

H-index: 12

I10-index: 13